Assault Weapons Ban of 2025
Summary
S. 1531, the Assault Weapons Ban of 2025, is an early-stage Senate bill that would prohibit civilian manufacture, sale, and transfer of semiautomatic assault weapons. Pure-play firearm manufacturers $SWBI and $RGR face existential revenue risk if enacted, but the bill remains at the referral stage with no committee markup or floor vote scheduled. Market data shows a modest 7-8% climb over 30 days as gun buyers front-run potential restrictions.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.S. 1531 is an early-stage bill with zero path to passage in the Republican-controlled House; real risk requires a Democratic trifecta after 2026 elections.
- 2.Current 30-day price gains of +7.89% for SWBI and +7.46% for RGR reflect preemptive retail buying, not expected enactment — the market is pricing in regulatory risk, not passage.
- 3.Pure-play firearm manufacturers SWBI and RGR face existential revenue risk only if passed; ammunition companies OLN and VSTO face secondary, smaller demand reduction.
Market Implications
The market has already partially priced in S. 1531 through a +7-8% run-up in SWBI and RGR over the last 30 days, reflecting 'buy-the-rumor' demand. This is a short-term revenue tailwind for manufacturers, not a sustainable bullish signal. Without a path to passage, the premium should fade. However, if the 2026 midterm elections deliver a Democratic trifecta (House + Senate + White House), this exact bill becomes a walking dead cat — a real legislative threat that would crater both stocks. Currently at $15.46 (SWBI) and $43.09 (RGR), near their 52-week highs of $15.74 and $48.21 respectively, the risk/reward is asymmetric: limited upside from here, but meaningful downside if the political landscape shifts. Investors should watch committee assignments and midterm polling as leading indicators.
Full Analysis
-
WHAT HAPPENED: Senator Adam Schiff (D-CA) introduced S. 1531 on April 30, 2025, the Assault Weapons Ban of 2025. The bill was read twice and referred to the Senate Judiciary Committee. It has 42 Democratic cosponsors, including leadership figures, but zero Republican support. A companion bill (HR 3115) exists in the House. The bill has not received committee markup or a floor vote. This is a standard reintroduction of a perennial Democratic priority.
-
THE MONEY TRAIL: This bill does not authorize or appropriate any government funding. It is a criminal regulatory bill that prohibits commerce in specific firearms. The financial impact is entirely negative on the supply side: manufacturers lose the right to produce and sell banned firearms. There is no compensation mechanism. The OMB has not published a cost estimate; the CBO would likely find negligible direct federal costs (prosecution is absorbed by DOJ operating budget) and a reduction in excise tax revenue from firearm sales.
-
STRUCTURAL WINNERS AND LOSERS: LOSERS — $SWBI (Smith & Wesson): Most exposed; modern sporting rifles are ~60%+ of revenue. $RGR (Sturm, Ruger): Also exposed but partially buffered by rimfire exemptions (.22 caliber) and traditional firearms. AMMUNITION COMPANIES $OLN (Olin, Winchester ammo) and $VSTO (Vista Outdoor) face secondary demand reduction as fewer semiautomatic rifles reduce ammunition consumption, but their civilian product lines are broader. $LMT (Lockheed Martin) is unaffected — the bill covers only semiautomatic firearms, not military/defense contracting. WINNERS: None directly in the firearm sector. Bolt-action and manual firearm manufacturers (e.g., $RGR's remaining lines, $SWBI's revolver segment) would face reduced competition from banned products but lose overall market foot traffic.
-
REAL MARKET DATA ANALYSIS: Over the 30 days ending April 30, 2026, $SWBI climbed +7.89% from $14.33 (approximate 30-day prior open) to $15.46, and $RGR climbed +7.46% from $40.10 to $43.09. This price action reflects 'buy-the-rumor' demand as retail buyers preemptively purchase firearms they believe may be banned, boosting near-term revenue. However, $OLN (Olin) fell -6.59% over the same period, defying the 'stampede buying' thesis for ammunition. The 7-day changes confirm continued buying: $SWBI +3.07%, $RGR +1.44%. Market data shows the 'panic buy' effect, not expected passage.
-
TIMELINE: The bill is at the earliest legislative stage. Path to enactment requires: (a) Judiciary Committee markup and vote, (b) full Senate floor debate and 60-vote threshold to overcome filibuster, (c) House passage of HR 3115 or companion bill, (d) Presidential signature. With 42 cosponsors (all Democrats) and a Republican-controlled House (119th Congress: House GOP majority), the bill has zero realistic path to law in this Congress. The midterm elections (November 2026) will determine 120th Congress control.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Criminal prohibition on import, sale, manufacture, transfer, or possession of semiautomatic assault weapons as defined by the bill
Who must act
Smith & Wesson Brands, Inc. — manufacturer of AR-15/M&P series rifles and other semiautomatic firearms meeting the 'semiautomatic assault weapon' definition in the bill
What happens
Smith & Wesson's primary revenue line (modern sporting rifles, including M&P15 and similar models) would become illegal to manufacture or sell for civilian use, eliminating ~50-70% of its revenue stream
Stock impact
Smith & Wesson's modern sporting rifle segment constitutes the majority of long-gun sales. With no grandfathering for future manufacture, the company faces immediate revenue collapse from its core product category. R&D, tooling, and inventory become stranded assets.
What the bill does
Criminal prohibition on import, sale, manufacture, transfer, or possession of semiautomatic assault weapons as defined by the bill
Who must act
Sturm, Ruger & Company, Inc. — manufacturer of the Ruger AR-556, Mini-14, and other semiautomatic rifles meeting the 'semiautomatic assault weapon' definition
What happens
Ruger's AR-556 and similar models, which represent a significant portion of their long-gun revenue, would be prohibited from manufacture and sale. Ruger's 10/22 (rimfire) is explicitly exempt, providing a limited revenue floor.
Stock impact
Ruger's modern sporting rifle and adjustable-stock semiautomatic lines would be banned. The rimfire exemption protects some revenue but the company faces major top-line contraction. Ruger's diversified catalog (revolvers, bolt actions) provides a partial buffer compared to SWBI.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
SHUSH Act
District of Columbia Firearm Freedom Act
SHUSH Act
To amend the Consumer Product Safety Act to remove the exclusion of pistols, revolvers, and other firearms from the definition of consumer product in order to permit the issuance of safety standards for such articles by the Consumer Product Safety Commission.
No Retaining Every Gun In a System That Restricts Your Rights Act
Protecting Access for Hunters and Anglers Act
Closing the Bump Stock Loophole Act of 2025
Firearm Access During Shutdowns Act of 2025
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →